The FDA assessed the protection and effectiveness of atidarsagene autotemcel determined by info from 37 young children who obtained atidarsagene autotemcel in two one-arm, open-label clinical trials As well as in an expanded accessibility application.[7] Kids who been given remedy with atidarsagene autotemcel had been when compared to untreated you